BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20111059)

  • 1. Identification of a 4.9-kilo base-pair Alu-mediated founder SDHD deletion in two extended paraganglioma families from Austria.
    Janecke AR; Willett-Brozick JE; Karas C; Hasipek M; Loeffler-Ragg J; Baysal BE
    J Hum Genet; 2010 Mar; 55(3):182-5. PubMed ID: 20111059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in the SDHD gene responsible for familial paraganglioma. Medical and psychological implications.
    Prontera P; Ferrando B; Giuliani V; Falcinelli F; Mencarelli A; Rogaia D; Pasini B; Donti E
    Genet Couns; 2008; 19(4):413-8. PubMed ID: 19239085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
    Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
    Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.
    Taschner PE; Jansen JC; Baysal BE; Bosch A; Rosenberg EH; Bröcker-Vriends AH; van Der Mey AG; van Ommen GJ; Cornelisse CJ; Devilee P
    Genes Chromosomes Cancer; 2001 Jul; 31(3):274-81. PubMed ID: 11391798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X.
    Simi L; Sestini R; Ferruzzi P; Gaglianò MS; Gensini F; Mascalchi M; Guerrini L; Pratesi C; Pinzani P; Nesi G; Ercolino T; Genuardi M; Mannelli M
    J Med Genet; 2005 Aug; 42(8):e52. PubMed ID: 16061558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic imprinting and environment in hereditary paraganglioma.
    Baysal BE
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):85-90. PubMed ID: 15264276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation of a common SDHB deletion in paraganglioma patients.
    Cascón A; Landa I; López-Jiménez E; Díez-Hernández A; Buchta M; Montero-Conde C; Leskelä S; Leandro-García LJ; Letón R; Rodríguez-Antona C; Eng C; Neumann HP; Robledo M
    J Med Genet; 2008 Apr; 45(4):233-8. PubMed ID: 18057081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss.
    Badenhop RF; Cherian S; Lord RS; Baysal BE; Taschner PE; Schofield PR
    Genes Chromosomes Cancer; 2001 Jul; 31(3):255-63. PubMed ID: 11391796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
    Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
    McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDH mutations in patients affected by paraganglioma syndromes: a personal experience.
    Mannelli M; Simi L; Ercolino T; Gaglianò MS; Becherini L; Vinci S; Sestini R; Gensini F; Pinzani P; Mascalchi M; Guerrini L; Pratesi C; Nesi G; Torti F; Cipollini F; Bernini GP; Genuardi M
    Ann N Y Acad Sci; 2006 Aug; 1073():183-9. PubMed ID: 17102085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
    Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
    J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?
    Cascón A; Montero-Conde C; Ruiz-Llorente S; Mercadillo F; Letón R; Rodríguez-Antona C; Martínez-Delgado B; Delgado M; Díez A; Rovira A; Díaz JA; Robledo M
    Genes Chromosomes Cancer; 2006 Mar; 45(3):213-9. PubMed ID: 16258955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma.
    Dannenberg H; Dinjens WN; Abbou M; Van Urk H; Pauw BK; Mouwen D; Mooi WJ; de Krijger RR
    Clin Cancer Res; 2002 Jul; 8(7):2061-6. PubMed ID: 12114404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
    Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
    Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
    Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
    Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
    Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
    Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.